Position Statements | Friends of the Court Briefs | Additional Society Policy Documents
Priorities and Positions
Under the guidance of our members we identify and act on issues that will impact the profession of endocrinology and patients with endocrine conditions. See how you can become involved and take action.
Our policy priorities include:
- Increased funding for the National Institutes of Health (NIH)
- Ensuring access to adequate, affordable healthcare
- Improved regulation of endocrine disrupting chemicals (EDCs) in the United States and internationally
- Realigning physician payment to recognize the value endocrinologists bring to the health care system
- Reduction in the prevalence of diabetes and obesity
- Protecting access to care for women and transgender patients
- Improved research policy
Position Statements
At the Endocrine Society, we are concerned about a number of critical policy issues. Our goals are to ensure that the full body of research available is available to policy makers and to affect positive change by advocating for increased research and updated regulatory processes.
- Compounded Bioidentical Hormone Therapy | September 2019
Compounded “Bioidentical” Hormone Therapy (cBHT), particularly estrogen and progesterone, have been promoted by… - Ensuring Affordable Access to Hormonal Contraception | May 2019
The majority of women of reproductive age in the United States currently use at least one contraceptive method… - Biomedical Research Funding | May 2019
A half century of sustained investment by the United States Federal Government in biomedical research has dramatically advanced the health and improved the lives of the American people… - Increasing Insulin Affordability | November 2018
Insulin is a lifesaving medication for people with diabetes. However, its cost has nearly tripled in the past fifteen years - Endocrine-Disrupting Chemicals | May 2018
Endocrine-disrupting chemicals (EDCs) are defined as: “an exogenous chemical, or mixture of chemicals, that can interfere with any aspect of hormone action”… - Endocrine-Disrupting Chemicals in the European Union | May 2018
The European Union (EU) has introduced specific legislative obligations aimed at phasing out endocrine disruptors… - Stem Cell Research | January 2018
Regenerative therapy using stem cells holds great promise for the treatment of millions of Americans... - Transgender Health | September 2017
Over the last few decades, there has been a rapid expansion in the understanding of gender identity… - Central Institutional Review Boards | April 2016
Clinical research involving human participants is critical to develop treatments for a broad… - Affordable Care Act Implementation: Challenges and Opportunities to Impact Patients With Diabetes | January 2016
In the United States, slightly more than half of all adults with diabetes receive… - Pediatric Obesity | November 2011
Pediatric obesity in the United States is an epidemic. Although obesity rates vary… - Bioequivalence of Sodium Levothyroxine | June 2008
The Endocrine Society is concerned that patients are frequently being placed at risk by the… - Access to Affordable and Adequate Diabetes Supplies | October 2007
Diabetes is a life-threatening disease affecting more than 20 million Americans… - Clinical Trial Registries | June 2006
In response to the growing public concern about the timely and complete reporting…
Friends of the Court Briefs
- Essential Access Health Inc v. HHS Secretary Azar | July 8, 2019
- Harris Funeral Homes v. EEOC | July 8, 2019
- Edmo v Idaho Department of Corrections | April 10, 2019
- Parents for Privacy v Dallas School District | March 11, 2019
- Adams v St. Johns County School Board | February 28, 2019
- Keohane v Florida Department of Corrections Secretary | January 9, 2019
- Jane Doe v President of the United States | October 29, 2018
- Good v Iowa Department of Human Services | September 4, 2018
- Richardson v Chicago Transit Authority | August 27, 2018
- Adams v St. Johns County School Board | July 26, 2018
- State of Washington v President of the United States | July 13, 2018
- American Diabetes Association v United States Department of the Army | June 28, 2018
- Appleberry v Blue Springs School District Board of Education | April 4, 2018
- Joel Doe v Boyertown Area School District and Pennsylvania Youth Congress Foundation | January 23, 2018
- Gloucester County School Board v Grimm | March 2, 2017
Additional Society Policy Documents
- 2019 Medicare Physician Fee Schedule Final Rule Summary | November 2018
- The Real Costs of Diabetes: What Policy Makers Need to Know Congressional Briefing Flier | October 1, 2018
- Richardson vs. Chicago Transit Authority | August 28, 2019
The Endocrine Society signed onto an amicus brief recognizing obesity as a disease and supporting its inclusion under the Americans with Disabilities Act’s definition of impairment. - Proposed Updates to Year 3 of the Quality Payment Program | July 2018
- CY 2019 Physician Fee Schedule Proposed Rule Summary | July 2018
- Fiscal Year (FY) 2017 Appropriations Summary | May 2017
- Priorities for Health System Reform | January 2017
The Endocrine Society outlines its core principles for policymakers to consider if healthcare reform is enacted. - Hypoglycemia Quality Collaborative Strategic Blueprint | October 2016
Report and Recommendations: A Resource to Increase Awareness of Hypoglycemia and Promote Activities to Reduce Its Incidence